WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for G1 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-03 1:33 pm Sale | 2020-12-31 | 13G | G1 Therapeutics, Inc. GTHX | WELLINGTON MANAGEMENT GROUP LLP | 1,237,342 3.250% | -1,719,213 (-58.15%) | Filing |
| 2020-09-09 09:10 am Sale | 2020-08-31 | 13G | G1 Therapeutics, Inc. GTHX | WELLINGTON MANAGEMENT GROUP LLP | 2,956,555 7.780% | -2,211,629 (-42.79%) | Filing |